Advertisement

Topics

Concert Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Company Update

07:00 EST 9 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Conference Call Scheduled Today at 8:30 a.m. EST Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the third quarter of 2017. “This is an exciting time for our deuterium-base...

Other Sources for this Article

Concert Pharmaceuticals, Inc.
Justine Koenigsberg (investors), 781-674-5284
ir@concertpharma.com
or
The Yates Network
Kathryn Morris (media), 914-204-6412
kathryn@theyatesnetwork.com

NEXT ARTICLE

More From BioPortfolio on "Concert Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Company Update"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...